Hematology: Clinical Trials
BESTIRON Clinical Trial
BESTIRON is a single-center, double-blinded, randomized, 12-week, superiority study that will compare the efficacy of NovaFerrum® to ferrous sulfate for the treatment of nutritional Iron Deficiency anemia in infants and young children as determined by increase in hemoglobin concentration.
Basic Eligibility Criteria:
- Age ≥ 9 months to < 48 months
- Nutritional Iron Deficiency Anemia documented by hematologic indices
For more information on the BESTIRON clinical trial, please contact:
Jacquelyn Powers, M.D.
Pediatric Hematology/Oncology Fellow
UT Southwestern Medical Center at Dallas
Leah Adix, CCRP
Clinical Research Coordinator
For more information on other open clinical trials, please contact:
Jacob Thurman, CCRP
Oncology, Stem Cell Transplant
Clinical Research Manager